SCHEMBL4429339

SCHEMBL4429339

CCOP(=O)(OCC)C(CCNOCc1ccccc1)c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.44
TP53 P04637 1/20 0.43
POLB P06746 4/20 0.42
RXFP1 Q9HBX9 1/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
GAA P10253 1/20 0.38
UTS2R Q9UKP6 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4423888 0.92 POLB (0.47) MAPTPOLBMEN1KMT2ANPSR1
SCHEMBL4433270 0.90 MEN1 (0.42) MAPTPOLBNPC1RAB9AMEN1
SCHEMBL4428141 0.88 MAPT (0.45) MAPTPOLBNPC1RAB9AMEN1
SCHEMBL29938335 0.88 MAPT (0.45) MAPTPOLBNPC1RAB9AMEN1
SCHEMBL4428097 0.88 NPC1 (0.44) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL27411079 0.78 POLB (0.40) MAPTPOLBRXFP1NPC1RAB9A
SCHEMBL4424406 0.75 MAPT (0.43) MAPTTP53POLBRXFP1GAA
SCHEMBL4426621 0.74 POLB (0.44) MAPTPOLBRAB9AMEN1KMT2A
SCHEMBL4428732 0.74 MAPT (0.41) MAPTTP53POLBRXFP1MEN1
SCHEMBL4428728 0.74 MAPT (0.41) MAPTTP53POLBRXFP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638505-B2 Organophosphoric derivatives useful as anti-parasitic agents UNIVERSITEIT GENT (BE) 2009-12-29 US disclosed
US-20080312190-A1 Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents UNIVERSITEIT GENT (BE) 2008-12-18 US disclosed
EP-1963344-A1 ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS UNIVERSITEIT GENT (BE) 2008-09-03 EP disclosed
WO-2007071453-A1 ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS UNIVERSITEIT GENT (BE) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312190-A1 Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents SUB1, CBR1, NAT1 MAPT 4756/4885TP53 3913/4885POLB 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.